Accessing GLP-1 treatment in Sonoma, California has traditionally meant longer waits than mainland patients face. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Sonoma address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Sonoma is already seeing results
Rybelsus in Sonoma, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Sonoma from $199/month with virtual consultations and direct-to-door shipping.
For many people in Sonoma, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk, approved in 2019 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Sonoma.
Suburban life around Sonoma comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Semaglutide therapy addresses biology involved in weight regulation by reducing hunger signals, so Sonoma area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month, delivered to your door. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.